FDA Inspection Report Cites Theranos Used “Uncleared Medical Device” | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

FDA Inspection Report Cites Theranos Used “Uncleared Medical Device”

October 27, 2015
by Heather Landi
| Reprints

The U.S. Food and Drug Administration found flaws in the process that medical testing company Theranos used to validate its blood-testing products, according to inspections reports the agency posted to its website.

The FDA has posted two inspection reports to its website based on inspections conducted August 25th through September 16th at Theranos’ Palo Alto, Calif. and Newark, N.J. facilities.

Healthcare Informatics obtained access to the FDA inspection reports from a link in an online article posted by Bloomberg Business.

Theranos is a biomedical startup that has developed technology for a blood testing device that requires only a finger prick blood sample for lab tests, as opposed to patients’ getting their blood drawn via a needle in a doctor’s office or lab, which often requires vials of blood.

One inspection report, which is heavily redacted, states that the “design validation did not ensure the device conforms to defined user needs and intended uses” and that the “design was not validated under actual or simulated use conditions.”

In a second inspection report for Theranos, Inc., the FDA states that the company’s “capillary tube nanotainer (CTN), a blood specimen collection device,” which refers to the small vials the company uses for the finger stick blood sample, is a “Class II medical device,” yet Theranos listed the device as a “Class I exempt medical device.”

The inspection report states, “You are currently shipping this uncleared medical device in interstate commerce, between California, Arizona and Pennsylvania.”

According to the Bloomberg Business article, the company said it had “addressed and corrected all the observations at the time of, or within a week of, the inspection.”

While Theranos lists about 200 tests on its online menu, the company said this month that it is using its new technology on only one test.



Appalachia Project to Study Relationship Between Increased Broadband Access, Improved Cancer Care

The Federal Communications Commission and the National Cancer Institute have joined forces to focus on how increasing broadband access and adoption in rural areas can improve the lives of rural cancer patients.

Survey: By 2019, 60% of Medicare Revenues will be Tied to Risk

Medical groups and health systems that are members of AMGA (the American Medical Group Association) expect that nearly 60 percent of their revenues from Medicare will be from risk-based products by 2019, according to the results from a recent survey.

83% of Physicians Have Experienced a Cyber Attack, Survey Finds

Eighty-three percent of physicians in a recent survey said that they have experienced some sort of cyber attack, such as phishing and viruses.

Community Data Sharing: Eight Recommendations From San Diego

A learning guide focuses on San Diego’s experience in building a community health information exchange and the realities of embarking on a broad community collaboration to achieve better data sharing.

HealthlinkNY’s Galanis to Step Down as CEO

Christina Galanis, who has served as president and CEO of HealthlinkNY for the past 13 years, will leave her position at the end of the year.

Email-Related Cyber Attacks a Top Concern for Providers

U.S. healthcare providers overwhelmingly rank email as the top source of a potential data breach, according to new research from email and data security company Mimecast and conducted by HIMSS Analytics.